Friday, 6 November 2026European Markets

SERGEFERRARI GROUP And KINGSPAN GROUP PLC Have A High Dividend Yield And Return On Equity In The Building Products & Equipment Industry.

Loading stream...

(vianews) - sergeferrari group (sefer.pa) is among this list of stock assets with the highest dividend rate and return on equity on the building products & equipment industry.

financial asset price forward dividend yield return on equity
sergeferrari group (sefer.pa) €13.56 2.88% 13.51%
kingspan group plc (krx.ir) €60.04 0.78% 19.39%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. sergeferrari group (sefer.pa)

2.88% forward dividend yield and 13.51% return on equity

sergeferrari group sa designs, manufactures, and distributes flexible composite materials in france and internationally. the company offers solutions for indoor and outdoor blind, and terrace blind and awning; tensile roof, shading structure, and big top; indoor and outdoor acoustic treatment; bioclimatic facade; building construction and renovation; and waterproof breathable membrane applications. it also provides products and solutions for modular structure, visual communication for printed advertisement, protection and environment, and yachting applications. in addition, the company offers sling seats for outdoor and contract furniture and upholstery for indoor and outdoor furniture. further, it provides antiviral technology on surfaces dedicated for indoor applications. the company was founded in 1973 and is headquartered in saint-jean-de-soudain, france.

earnings per share

as for profitability, sergeferrari group has a trailing twelve months eps of €0.04.

pe ratio

sergeferrari group has a trailing twelve months price to earnings ratio of 339. meaning, the purchaser of the share is investing €339 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.51%.

yearly top and bottom value

sergeferrari group's stock is valued at €13.56 at 12:40 est, way below its 52-week high of €19.54 and way above its 52-week low of €9.52.

dividend yield

according to morningstar, inc., the next dividend payment is on apr 26, 2023, the estimated forward annual dividend rate is 0.4 and the estimated forward annual dividend yield is 2.88%.

revenue growth

year-on-year quarterly revenue growth grew by 19.5%, now sitting on 338.7m for the twelve trailing months.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, sergeferrari group's stock is considered to be overbought (>=80).

more news about sergeferrari group.

2. kingspan group plc (krx.ir)

0.78% forward dividend yield and 19.39% return on equity

kingspan group plc, together with its subsidiaries, provides insulation and building envelope solutions in western and southern europe, central and northern europe, the americas, and internationally. it operates through six segments: insulated panels, insulation, light + air, water + energy, data + flooring, and roofing + waterproofing. the insulated panels segment manufactures insulated panels, structural framing, and metal facades. the insulation segment produces rigid insulation boards, technical insulation, and engineered timber systems. the light + air segment offers daylighting, smoke management, ventilation systems, and service activities. the water + energy segment provides energy and water solutions, and related services. the data + flooring segment manufactures data center storage solutions, as well as raised access floors. the roofing + waterproofing segment produces roofing and waterproofing solutions for renovation and new construction of buildings. kingspan group plc was founded in 1965 and is based in kingscourt, ireland.

earnings per share

as for profitability, kingspan group plc has a trailing twelve months eps of €2.04.

pe ratio

kingspan group plc has a trailing twelve months price to earnings ratio of 29.37. meaning, the purchaser of the share is investing €29.37 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.39%.

volatility

kingspan group plc's last week, last month's, and last quarter's current intraday variation average was a negative 1.95%, a negative 0.45%, and a positive 2.06%.

kingspan group plc's highest amplitude of average volatility was 1.95% (last week), 2.00% (last month), and 2.06% (last quarter).

revenue growth

year-on-year quarterly revenue growth grew by 17.1%, now sitting on 8.34b for the twelve trailing months.

dividend yield

as stated by morningstar, inc., the next dividend payment is on apr 13, 2023, the estimated forward annual dividend rate is 0.49 and the estimated forward annual dividend yield is 0.78%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, kingspan group plc's stock is considered to be overbought (>=80).

more news about kingspan group plc.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com